Comprehensive Guide to Angina: Types, Pathophysiology, and Pharmacologic Management
What Is Angina?
- Angina = central chest discomfort (pressure, heaviness, burning) that may radiate to arms, neck, jaw, or epigastrium.
- It reflects transient, reversible myocardial ischemia caused by an imbalance between oxygen supply and demand.
- Classic episodes last 15 seconds to 15 minutes; >20 minutes usually progresses to myocardial infarction.
Major Types of Angina
- Stable (Classical/Typical) Angina
- Fixed atherosclerotic plaque >70 % lumen narrowing.
- Ischemia occurs during exertion or emotional stress when the stenotic segment cannot dilate.
- Pain resolves with rest or sublingual nitrates.
- Variant (Prinzmetal) Angina
- Coronary artery vasospasm with little or no plaque.
- Can occur at rest, often in the early morning; more common in women.
- Not relieved by rest alone; responds to coronary vasodilators.
- Unstable Angina
- Unstable plaque (thin‑cap, inflamed) that ruptures, ulcerates, or hemorrhages.
- Platelet aggregation and thrombus formation cause dynamic obstruction.
- Pain is more severe, frequent, may occur at rest, and does not respond to nitrates or rest.
- If ischemia persists >20 minutes → myocardial infarction.
Core Therapeutic Principle
Reduce myocardial oxygen demand until it matches the limited supply. This is achieved by lowering: - Preload (venous return → end‑diastolic volume) - Afterload (arterial resistance) - Heart rate & contractility (chronotropy, inotropy)
Drug Classes & How They Fit the Principle
| Class | Primary Mechanism | Effect on Preload/Afterload/HR/Contractility | Typical Indications |
|---|---|---|---|
| Nitrates (glyceryl trinitrate, isosorbide dinitrate/mononitrate) | Release NO → ↑cGMP → venous (strong) & arterial (weak) dilation | ↓Preload (venous pooling) → ↓LV wall stress; modest ↓Afterload; improves collateral flow | First‑line for stable angina, acute relief (sublingual), prophylaxis (patches, oral SR) |
| Beta‑blockers (atenolol, metoprolol, propranolol) | Block β₁ receptors → ↓ SA‑node firing, ↓ AV‑node conduction, ↓ myocardial contractility | ↓Heart rate, ↓stroke volume, ↓afterload (via reduced sympathetic tone) | Stable angina, post‑MI, hypertension; combined with nitrates to blunt reflex tachycardia |
| Calcium‑channel blockers (dihydropyridines: amlodipine, nifedipine; non‑dihydro: verapamil, diltiazem) | Inhibit L‑type Ca²⁺ channels → smooth‑muscle relaxation & ↓ Ca²⁺‑dependent myocardial contraction | Dihydropyridines: ↓Afterload (arterial dilation); Non‑dihydro: ↓HR & contractility + modest arterial dilation | Variant angina (vasospasm) → dihydropyridines; add‑on for stable angina when nitrates/β‑blockers insufficient |
| Antiplatelet/Antithrombotic (aspirin, clopidogrel) | Inhibit platelet aggregation → prevent thrombus on unstable plaque | No direct hemodynamic effect | Long‑term secondary prevention, especially in unstable angina/ACS |
| Statins | HMG‑CoA reductase inhibition → LDL lowering & plaque stabilization | No direct hemodynamic effect | Chronic risk‑factor modification; reduces progression to unstable plaque |
Nitrates in Detail
- Sublingual: onset 1‑2 min, duration ~30 min – ideal for acute attacks.
- Oral SR/ER: onset 30 min, duration 6‑12 h – for prophylaxis.
- Transdermal patch: onset ~30 min, duration 8‑12 h.
- Tolerance develops after ~12‑16 h of continuous exposure; a 6‑8 h nitrate‑free interval restores responsiveness.
- Adverse effects: severe headache (meningeal vessel dilation), facial flushing, orthostatic hypotension, reflex tachycardia (mitigated by β‑blockers).
Beta‑Blockers: Key Points & Contra‑indications
- Reduce SA‑node automaticity → negative chronotropy.
- Reduce AV‑node conduction → negative dromotropy.
- Decrease contractility → negative inotropy.
- Do NOT use in uncontrolled asthma/COPD, severe bradyarrhythmias, insulin‑dependent diabetes with frequent hypoglycemia (masking warning signs), peripheral vasospastic disorders (Raynaud), major depression, or acute decompensated heart failure.
- Abrupt discontinuation after long‑term use can cause rebound tachycardia and hypertension due to β‑receptor up‑regulation.
Calcium‑Channel Blockers: Nuances
- Dihydropyridines (amlodipine, nifedipine) act mainly on arterial smooth muscle → ↓afterload, useful for vasospastic (Prinzmetal) angina.
- Non‑dihydro (verapamil, diltiazem) have stronger cardiac effects → ↓HR, ↓AV‑node conduction, modest arterial dilation; useful when heart‑rate control is needed.
- Side‑effects mirror nitrates for dihydropyridines (headache, flushing) and β‑blockers for non‑dihydro (fatigue, bradycardia, possible heart block).
- Excessive dosing can cause reflex tachycardia (due to blood‑pressure drop) or sinus arrest/complete heart block; combining with a β‑blocker or using a cardio‑selective CCB mitigates this.
Integrated Management Strategy
- Acute Relief – Sublingual nitroglycerin ± oxygen; if pain persists, consider IV nitrates and add β‑blocker.
- Chronic Control –
- First line: Nitrates (long‑acting) + β‑blocker.
- Add‑on: Dihydropyridine CCB if angina persists or for variant angina.
- Alternative: Non‑dihydro CCB when β‑blocker contraindicated.
- Plaque Stabilization & Risk‑Factor Modification – Statins, aspirin, smoking cessation, blood‑pressure & diabetes control, regular aerobic exercise.
- Revascularization – PTCA (angioplasty) or CABG for >90 % stenosis or refractory symptoms despite optimal medical therapy.
Practical “Donkey” Analogy Recap
- Heart = donkey carrying a load (preload) up a slope (afterload) many times per minute.
- Ischemic donkey cries (angina) when the load or slope is too high.
- Therapy = lighten the load (venodilators), smooth the slope (arteriolar dilators), and slow the donkey’s steps (β‑blockers/CCBs) so it can work without pain.
Quick Reference Table
| Situation | Preferred Drug(s) |
|---|---|
| Stable exertional angina | Sublingual nitrate + β‑blocker; add dihydropyridine CCB if needed |
| Variant (Prinzmetal) angina | Dihydropyridine CCB (nifedipine/amlodipine) ± long‑acting nitrate |
| Unstable angina | Immediate antiplatelet (aspirin), anticoagulation, possible IV nitrates; β‑blocker if no contraindication; early invasive strategy |
| Contra‑indication to β‑blocker (asthma) | Nitrate + dihydropyridine CCB |
| Severe hypertension with angina | Combine CCB (afterload reduction) with nitrate; avoid reflex tachycardia by adding β‑blocker if tolerated |
Monitoring & Follow‑Up
- Assess frequency/intensity of chest pain, exercise tolerance, and side‑effect profile.
- Verify nitrate‑free interval to prevent tolerance.
- Check heart rate and blood pressure after initiating β‑blocker or CCB.
- Lipid panel, HbA1c, and smoking status every 3‑6 months for secondary prevention.
When to Escalate
- Pain lasting >20 minutes despite maximal medical therapy.
- New‑onset rest pain, dynamic ECG changes, or rising cardiac biomarkers → treat as acute coronary syndrome and consider urgent revascularization.
Effective angina control hinges on matching myocardial oxygen demand to its limited supply—by reducing preload, afterload, heart rate, and contractility—using nitrates, beta‑blockers, and calcium‑channel blockers, while also stabilizing plaques with statins and antiplatelet agents and addressing lifestyle risk factors.
Frequently Asked Questions
Who is Dr. Najeeb Lectures on YouTube?
Dr. Najeeb Lectures is a YouTube channel that publishes videos on a range of topics. Browse more summaries from this channel below.
Does this page include the full transcript of the video?
Yes, the full transcript for this video is available on this page. Click 'Show transcript' in the sidebar to read it.
What Is Angina?
- Angina = central chest discomfort (pressure, heaviness, burning) that may radiate to arms, neck, jaw, or epigastrium. - It reflects **transient, reversible myocardial ischemia** caused by an imbalance between oxygen supply and demand. - Classic episodes last **15 seconds to 15 minutes**; >20 minutes usually progresses to myocardial infarction.
When to Escalate
- Pain lasting >20 minutes despite maximal medical therapy. - New‑onset rest pain, dynamic ECG changes, or rising cardiac biomarkers → treat as acute coronary syndrome and consider urgent revascularization. --- Effective angina control hinges on matching myocardial oxygen demand to its limited supply—by reducing preload, afterload, heart rate, and contractility—using nitrates, beta‑blockers, and calcium‑channel blockers, while also stabilizing plaques with statins and antiplatelet agents and addressing lifestyle risk factors.
Helpful resources related to this video
If you want to practice or explore the concepts discussed in the video, these commonly used tools may help.
Links may be affiliate links. We only include resources that are genuinely relevant to the topic.